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Cultured enterocytes internalise 
bacteria across their basolateral 
surface for, pathogen-inhibitable, 
trafficking to the apical 
compartment
Paul Dean1, Sabine Quitard1, David M. Bulmer1, Andrew J. Roe2 & Brendan Kenny1
In vitro- and in vivo-polarised absorptive epithelia (enterocytes) are considered to be non-phagocytic 
towards bacteria with invasive pathogenic strains relying on virulence factors to ‘force’ entry. Here, 
we report a serendipitous discovery that questions these beliefs. Thus, we uncover in well-established 
models of human small (Caco-2; TC-7) and large (T84) intestinal enterocytes a polarization-dependent 
mechanism that can transfer millions of bacteria from the basal to apical compartment. Antibiotic-
protection assays, confocal imaging and drug inhibitor data are consistent with a transcellular route 
in which internalized, basolateral-membrane enclosed bacteria are trafficked to and across the apical 
surface. Basal-to-apical transport of non-pathogenic bacteria (and inert beads) challenged the idea of 
pathogens relying on virulence factors to force entry. Indeed, studies with Salmonella demonstrated 
that it’s entry-forcing virulence factor (SPI-I) was not required to enter via the basolateral surface but 
to promote another virulence-associated event (intra-enterocyte accumulation).
Infection studies with non-polarisable epithelial cells, such as HeLa, helped to establish the con-
cept of enterocytes being non-phagocytic towards bacteria—a premise supported by the discovery of 
pathogen-encoded virulence factors to force entry1–3. However, non-polarisable cells lack key features of 
enterocytes, such as absorptive microvilli, due to their inability to form tight junctional (TJ) complexes 
between neighbouring cells which provides ‘barrier’ (to limit the unregulated paracellular movement of 
ions, fluids and macromolecules) and ‘fence’ (to prevent the diffusion of membrane components between 
apical [lumen-facing] and basolateral [host-privileged surfaces]) functions4,5. Fence functionality is also 
critical for the targeted accumulation of cellular components to generate specialised features, such as, 
transporter-rich absorptive microvilli and enriching immune response-inducing antigen receptors on 
host-privileged surfaces. Enterocytes originate from crypt-located stem cells in a partially-polarised state 
with migration up the intestinal villus leading to the fully polarised/differentiated form4,5. While most 
epithelial cells differentiate into enterocytes others specialise to provide specific host-protective functions, 
including, mucus secretion (Goblet cells), releasing anti-microbial factors (Paneth cells) and sampling 
luminal contents (M-cells) for presentation to immune cells4,5. The physiological importance of epithelial 
barrier function in the gut is illustrated by the linkage of genetic-, environmental- and infection-related 
dysfunction to diarrhoeal, inflammatory and systemic disease4,5. Immortalised Caco-2 cells polarised on 
porous membranes (in Transwell inserts) provide a well-established model for enterocytes of the human 
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small intestine that we have used to interrogate how a classic non-invasive enteric pathogen, enteropath-
ogenic E.coli (EPEC), triggers disease-associated alterations6–9. Here, we describe how an unorthodox 
EPEC infection protocol revealed cultured enterocytes to have an unrecognised capacity to internalise 
bacteria (pathogens, non-pathogens and bacterial-sized beads) for transcellular translocation from the 
basolateral to apical compartment thereby challenging important beliefs about the biology of cultured 
enterocytes and invasive bacterial pathogens.
Results
Polarisation-dependent asymmetric translocation of E.coli across monolayers of cultured 
enterocytes. Caco-2 enterocytes (polarised on membranes containing 3 μ m pores in Transwell 
inserts) were infected with EPEC at the basolateral side to investigate whether interaction at this, nor-
mally inaccessible, surface would trigger disease-associated alterations. Unexpectedly, this work indicated 
that EPEC could access the opposite (apical) compartment in a manner independent of its main viru-
lence factor—a Type Three Secretion Systems (T3SS) that transfer ‘effector’ proteins into enterocytes6. To 
further investigate this finding, a simple quantitative plating assay was used to monitor bacterial move-
ment in the basolateral-to-apical (BtA) and apical-to-basolateral (AtB) directions (Fig. 1a). These assays 
involved a Caco-2 subclone, TC-7, to reduce possible issues from the recognised heterogeneity of cell 
types in the Caco-2 model10,11. As reported12, few EPEC (wildtype or avirulent T3SS-deficient mutant bac-
teria) translocated in the AtB direction with our data revealing significantly more (~2500 fold) wildtype 
EPEC (Fig. 1b; p = 0.006) translocating in the other (BtA) direction. Similar results were obtained with 
the T3SS mutant and non-pathogenic laboratory K12 (DH10B) E.coli strains (Fig.  1b) thereby uncou-
pling the translocation event from pathogen-encoded factors. Thus, further studies focused on DH10B 
where extended (3 hr) infections—which do not disrupt epithelia barrier functionality as assessed by 
transepithelial electrical resistance/TER measurements (Supplementary Figure S1 online)—revealed an 
even more dramatic asymmetric BtA:AtB translocation ratio (~40,000:1; Fig.  1c). Similar asymmetric 
translocation ratios were obtained for polarised Caco-2 and T84 cells (Fig. 1d); the latter a well-estab-
lished model for enterocytes of the human large intestine13. The latter findings contrasted to symmetrical 
translocation profiles with confluent monolayers of HeLa cells (Fig.  1d) tentatively linking the asym-
metric translocation process with the enterocyte polarisation/differentiation process. To interrogate the 
latter possibility studies were undertaken with TC-7 cells at different differentiation stages. As expected, 
infection of non-polarised TC-7 cells (1 day post-confluence; low TER value) led to symmetrical trans-
location ratios while differentiation—as evidenced by increasing TER values (Fig.  1e)—was associated 
with a developing asymmetrical bacterial translocation which was maximal for fully polarised (15 days 
post-confluence) cells (Fig.  1e). Time course infections revealed that few bacteria (~900) translocated 
in the AtB direction over a 5 hr infection period (Fig. 1f). By contrast, ~1000 and ~20,000 times more 
bacteria translocated in the BtA direction by 0.5 and 5 hr post-infection, respectively with ~18 million 
recovered from the apical compartment by experiment end (Fig. 1f,g). Thus, the enterocyte polarisation 
process provides a mechanism that enables host cells to translocate bacteria across the monolayer in a 
BtA-biased manner.
BtA bacterial translocation via a transcellular route. As the TER data argued against disruption 
of cell-cell interactions (Supplementary Figure S1 online) which would enable paracellular translocation, 
studies focused on a transcellular route. Indeed, standard antibiotic (gentamicin) protection assays revealed 
that apical infections led to few intracellular bacteria (156+ /− 60) while basolateral infections resulted in 
significantly more (~258 fold; p < 0.01) intracellular bacteria (Fig. 2a). Importantly, confocal imaging of 
basolaterally-infected monolayers revealed E.coli beneath the support membrane, at the cell-substratum 
interface, above the actin-rich microvillus surface and, apparently, within enterocytes (Fig. 2b). To illus-
trate an intracellular location, the basolateral surface was labelled (using WGA-FITC) prior to basolat-
eral infection, with confocal imaging revealing intracellular bacteria enclosed by FITC-labelled material 
(Fig.  2c). Given the clonal nature of the cell model it was surprising that < 105 bacteria (Fig.  2a) were 
recovered from a monolayer (~106 enterocytes); but consistent with confocal imaging studies. The latter 
suggested that the transcellular translocation process involved a subset of cells or, more likely, that uptake 
was limited by the need for the bacteria (~0.5 × 2 μ m in size expressing pili and/or flagella [1–3 μ m]) 
to transit the 10 μ m thick Transwell membrane via a limited number (~2 × 106) of 3 μ m pores in order 
to access the basolateral surface. To interrogate the latter possibility, monolayers were pre-treated with 
EDTA to disrupt cell-cell interactions with the expectation that this would provide apically-added bac-
teria greater (paracellular-mediated) access to the basolateral surface and, thus, increased internalisation 
levels. Indeed, EDTA-treatment disrupted epithelial barrier function (Fig.  2d) and while it had little 
impact on the number of BtA translocating bacteria (Fig.  2e) it dramatically increased the number of 
AtB translocating bacteria (> 1000 fold; p = 0.001) with, as predicted, many more apically-added bacteria 
recovered from within cells (Fig. 2f; > 100 fold; p < 0.001). However, the latter increase in intracellular 
bacterial numbers was surprisingly only to the level of standard basolateral infections (Fig. 2f versus 2a) 
suggesting that EDTA refractory cell-cell interactions continue to limit access of apically-added bacteria 
to the basolateral surface. In an additional strategy, enterocytes polarised on glass coverslips were phys-
ically ‘wounded’ before apically infecting with GFP-expressing DH10B and determining, via antibody 
labelling, if the cell-associated bacteria where intra- or extra-cellular. While enterocytes away from the 
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Figure 1. Basolateral-to-apical (BtA) translocation of E.coli across intact enterocyte monolayers. The 
apical or basolateral surfaces of non-polarisable (HeLa) or polarised (TC-7 and, in c, Caco-2 and T84) 
cell monolayers were inoculated with bacteria for 30 minutes—or indicated time—with media taken from 
the opposite compartment at indicated times for plating on agar (a) with the resulting counts plotted 
(logarithmic scale; (b–f)) as mean ± SD [error bars] from three independent experiments with *** indicating 
statistically significance (One-way ANOVA with Tukey Post Hoc Test) of p < 0.001. Monolayers were 
infected with enteropathogenic E.coli (EPEC)—wildtype (WT) or avirulent (T3SS-deficient) mutant—or 
innocuous K12 E.coli (DH10B). Polarised Caco-2/TC-7 and T84 cells are established models of human small 
and large intestinal enterocytes. AtB indicates infected apical surface taking samples from the basolateral 
well for enumerating bacterial numbers (opposite for BtA). The BtA:AtB ratio is provided alongside the 
Transepithelial Electrical Resistance (TER) value showing mean ± SD [error bars] from three independent 
experiments (e) with a time course study in (f). Note the error bars are often too small to detect. Graph 
illustration of data with MV and TJ indicating microvilli and tight junctions respectively (g).
www.nature.com/scientificreports/
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Figure 2. Transcellular bacterial translocation pathway. Polarised TC-7 cells were incubated with 
innocuous (DH10B) E.coli (a–f)—expressing EGFP (Green; a,b) or RFP (Red; (c))—or 1 μ m fluorescent latex 
beads (Green; (g–i)). Monolayers (d–f) were pre-treated with (+ ) or without (− ) 10 mM EDTA to disrupt 
barrier function—illustrated by decreasing Transepithelial Electric Resistance [TER] (d)—prior to infection. 
Numbers of translocating (e) or intracellular (a,f) bacteria is shown. Graphed data is mean ± SD [error bars] 
from three independent experiments with ** and *** indicating statistically significance (One-way ANOVA 
with Tukey Post Hoc Test) of p ≤ 0.01 and p ≤ 0.001 respectively. AtB indicates infected apical surface 
taking samples from the basolateral well for enumerating bacterial numbers (opposite for BtA). Monolayers 
(b,c,g–i) were fixed and stained for filamentous actin (Red; (b,g–i)) or DNA (host and bacterial, Blue; (c)). 
The basolateral surface was pre-labelled with FITC-conjugated wheat germ agglutinin (Green; (c)) prior to 
basolateral infection with confocal imaging signal intensity in the different channels along 2.34 μ m yellow 
line shown: ‘Blue’ (bacterial DNA), ‘Red’ (bacterial RFP) and ‘Green’ (WGA-labelled basolateral membrane). 
Micrographs (b,g,h) are composites of 45–60 xy serial confocal-acquired sections (0.5 μ m steps) with (i) 
an aerial view of the apical surface of monolayer shown in (h). M and S indicate position of cortical actin/
microvillar region and Transwell porous support respectively (b,g,h).
www.nature.com/scientificreports/
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wound sites had few cell-associated bacteria which were mostly extracellular (~80%; 962/1172) those 
close to the wound sites (Supplementary Figure S2 online) were mostly intracellular (~71%; 1143/1581). 
Replacement of bacteria for bacterial-sized fluorescent (1 μ m) beads indicated that they were also inter-
nalised (Supplementary Figure S3 online) prompting imaging studies with cells polarised in Transwells. 
Such studies clearly revealed these inert particles to be substrates for internalisation into and across 
enterocytes, but only when added to the basolateral surface (Fig. 2g–i) supporting the findings with the 
bacteria. Collectively, the work reveals enterocytes have a polarisation-dependent capacity to internalise 
bacterial-sized particles which interact with their basolateral surface for transcellular translocation to 
the apical compartment.
Transcellular trafficking of bacteria to and across the apical surface. Confocal imaging of the 
cortical actin—a recognised obstacle to trafficking events14 – unexpectedly revealed bacterial-sized ‘voids’—
usually associated with bacteria (Fig.  3a,b)—that were rare in control (uninfected or apically-infected) 
monolayers with ~9 fold more for basolaterally-infected monolayers (Fig.  3c; p < 0.005). Thus, bacte-
rial interaction with the basolateral surface appears to not only trigger uptake but also rearrangement 
of the cortical actin to enable internalised (membrane-enclosed) bacteria to be trafficked to the apical 
membrane for release into the apical compartment, presumably via an exocytosis-mediated event. A key 
role for the host actin and microtubule cytoskeletal networks in the uptake and BtA translocation pro-
cesses was supported by dramatic reductions (Fig. 3d; p < 0.001) when monolayers were pre-incubated 
with inhibitors of vesicular-trafficking (nocodazole) or actin polymerisation (cytochalsinD) events. The 
smaller impact of cytochalsinD, compared to nocodazole (p = 0.043, on bacterial BtA translocation is 
Figure 3. BtA bacterial translocation linked to cortical cytoskeletal rearrangement and transcellular 
trafficking events. Polarised TC-7 cells were infected at the basolateral surface with EGFP-expressing 
innocuous (DH10B) E.coli (Green). Monolayers (a–c) were fixed and stained for filamentous actin (Red) 
with confocal imaging revealing actin-negative ‘voids’ (a,b) that were quantified (c; data is mean ± SD [error 
bars] from three independent experiments, with *** indicating statistically significance (One-way ANOVA 
with Tukey Post Hoc Test) of p < 0.001). Micrographs (a, and larger panels in (b)) show xy-surface views 
with smaller panels (b) showing xz-sections. Ctr. indicates uninfected with BtA indicating that infected the 
basolateral surface (c). Monolayers (d) were left untreated (No Drug) or pre-treated with cytochalsin D 
(CytoD) or nocodazole (Noc) prior to infecting the basolateral surface with DH10B E.coli and enumerating 
the number of bacteria that reached the apical compartment (top panel) or were within (bottom panel) 
enterocytes. Data is mean ± SD [error bars] from 3 independent experiments shown as percentage recovered 
relative to No drug control (set at 100%) or between indicated data sets. * and *** indicating statistically 
significance (One-way ANOVA with Tukey Post Hoc Test) of p < 0.05 and p < 0.001, respectively compared 
to No drug control with n.s. indicating no significant difference.
www.nature.com/scientificreports/
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associated with it disrupting epithelial barrier function (Supplementary Figure S4 online)—an event 
linked to enabling paracellular bacterial translocation (Fig.  2d, e). Thus, BtA translocation of bacteria 
across the enterocyte monolayer involves a transcellular route that, like the uptake process, depends on 
the cells retaining fully functional microtubule and actin networks.
SPI-1 independent uptake and transcellular translocation of basolateral-infecting 
Salmonella. The uptake of innocuous E.coli (and bacterial-sized beads) across the basolateral sur-
face questioned the belief that invasive pathogens rely on virulence factors to force entry. Thus, stud-
ies were carried out with a classic invasive enteric pathogen, Salmonella enterica serovar Typhimurium 
(S. Typhimurium) and an isogenic mutant that lacks the T3SS (SPI-1) linked to forced cellular entry15,16. 
Standard apical infections confirmed strain genotype since, as reported16, wildtype S. Typhimurium, but 
not the SPI-1 mutant disrupted epithelia barrier function (Fig. 4a), with the SPI-1 virulence factor playing 
a prominent role in enabling Salmonella to translocate in the AtB direction (Fig. 4b). Crucially, consistent 
Figure 4. The Salmonella Typhimurium SPI-1 effector-delivery system is not required to enter 
enterocytes via the basolateral surface but promotes their intracellular accumulation. Polarised TC-7 
cells were infected with Salmonella Typhimurium strains—wildtype [Salm.] or T3SS-deficient [SPI-1] 
mutant—or innocuous K12 (DH10B) E.coli at the apical (a,b) or basolateral (c–e) surfaces. Transepithelial 
Electrical Resistance (TER) changes were monitored (a) with bacterial translocation in AtB (b) or BtA  
(c) directions quantified following 30 min infections. AtB indicates infected apical surface taking samples 
from the basolateral well for enumerating bacterial numbers (opposite for BtA). Gentamicin-protection 
assays revealed the number of basolaterally-added bacteria that entered into enterocytes following 30 minute 
(d) or indicated (e) infection time periods. Data is mean ± SD [error bars] from three independent 
experiments with ** and *** indicating statistically significance (One-way ANOVA with Tukey Post Hoc 
Test) of p < 0.01 and p < 0.001 respectively with n.s. indicating no significant difference.
www.nature.com/scientificreports/
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with our data, SPI-1 functionality was found not to be required for basolaterally-added Salmonella to 
cross the monolayer (Fig. 4c) or to enter into the cells where significantly more were recovered compared 
to DH10B K12 E.coli (Fig.  4d; p = 0.006). Indeed, the BtA translocation data suggested that the SPI-1 
mutant may translocate at greater, though not statistically significant (Fig. 4c; p = 0.6), numbers than the 
wildtype strain suggesting that SPI-1 functionality may inhibit the BtA translocation process and promote 
intra-cellularity. To investigate the latter possibility, time course studies were undertaken which revealed 
similar numbers of intracellular bacteria for both Salmonella strains following a short (30 min; p = 0.6) 
infection period with significantly fewer intracellular SPI-1 mutant bacteria at later—180 (p < 0.02) or 
300 (p < 0.002) minute – post-infection time points (Fig. 4e). Thus, Salmonella does not require SPI-1 
functionality to enter enterocytes via the basolateral surface but, by contrast, this virulence-critical factor 
promotes another virulence-associated event; intra-enterocyte accumulation.
Discussion
Here we clearly show the polarisation process that generates well-established models for enterocytes of 
the human small (Caco-2; TC-7) and large (T84) intestine produces a transcellular transport pathway 
with a, hitherto unrecognised, capacity to transfer millions of bacteria from the basolateral to apical com-
partment. Such biology presumably remained cryptic due to pioneering infection studies—prior to the 
development of enterocyte models—with non-polarised cells establishing the concept of epithelia being 
non-phagocytic towards bacteria unless the bacteria encode virulence factors to force entry. Indeed, 
when polarisable epithelia were used such studies invariably involved i) pathogens that can force entry, ii) 
partially polarised cells—herein linked to low levels of BtA bacterial translocation, or iii) cells polarised 
on surfaces that only support apical infection. It is also possible that differences in reagents, cell mod-
els and/or experimental protocols contributed to a delay in appreciating the BtA bacterial transcellular 
translocation potential of cultured enterocytes. While AtB translocation was also evident, it was a much 
rarer event that probably relates to a paracellular translocation route. Our findings suggest that polarised 
Caco-2, TC-7 and T84 cells should be considered non-conventional phagocytes17 as they can internalise 
bacterial-sized particles across their basolateral surface for trafficking, not for intracellular degradation 
as per professional phagocytes, but to the opposite (apical) surface for expulsion. While, it is known that 
many invasive pathogens need to access (eg Shigella flexneri) or have a preference for (eg Salmonella 
Typhimurium and Campylobacter jejuni) the basolateral surface to enter into cultured enterocytes the 
uptake mechanism was assumed, until now, to depend on pathogen-encoded virulence factors16,18,19. 
Our findings raise the intriguing possibly that this polarisation-dependent biology may also be present 
in other polarisable epithelial, and perhaps endothelial, cell lines.
Despite the simplicity of our cultured model system—which lack specialised epithelial cells (stem, 
goblet, paneth, enteroendocrine, M-cells), underlying tissue and immune cells—it raises the provocative 
possibility that our findings may reflect an underappreciated existence of such polarisation-dependent 
biology in gut enterocytes. The latter hypothesis is not so unreasonable given increasing in vivo evi-
dence for polarised epithelia being able to phagocytose larger particles (cells) while immune cells can 
move between and though endothelia20–24. Indeed, many invasive bacterial pathogens must, or can tran-
sit though M-cells in vivo to access the enterocyte basolateral surface for entry with one, Salmonella 
Typhimurium, recently shown to promote invasion by reprogramming adjacently-infected epithelia into 
M-cells25,26. Our findings may also help to explain why invasive enteric pathogens often target the basolat-
eral surface in vivo—not only via M-cells but by disrupting cell-cell interactions or targeting the surface 
as cells slough-off 25—to engage the host-mediated uptake mechanism with virulence factors required, 
not to force entry but to inhibit expulsion via the BtA translocation pathway. We suggest that the BtA 
bacterial translocation pathway may be an unrecognised part of an enterocyte’s anti-infective function-
ality where it acts to provide a means to return into the gut lumen those rare bacteria that manage to 
access the basolateral surface—due to background ‘leakiness’ or disruption (through injury, infection or 
genetic defects)—while antigen receptor activation of immune responses initiate additional defensive 
measures. A phagocytic basolateral surface could also explain why disorders associated with bacteria 
crossing the gut barrier, such as inflammatory bowel disease (IBD), are linked with normally-harmless, 
non-invasive bacteria not only entering into the blood system but also into enterocytes5,27–30. Such BtA 
bacterial translocation biology, if verified, would undermine the linkage of IBD to an ‘invasive’ bacterial 
phenotype31–33—a correlation already questioned by the ability of a classic non-invasive pathogen (EPEC) 
to force entry into non-polarised cells34. Our findings should stimulate the undertaking of challenging 
live cell-imaging studies to interrogate the in vivo relevance of our discovery and to define the relation-
ship of the uptake and/or BtA translocation processes to those described for the phagocytosis and/or 
BtA translocation of larger (epithelia)20–24 and smaller (viruses and sIgA protein complex) particles35,36.
In summary, our work clearly reveals an unrecognised property of cultured enterocytes extensively 
used in industry and academia10,11 with important implications for understanding the biology of invasive 
bacterial pathogens and enterocytes in vitro and in vivo.
Methods
Bacterial strains, plasmids and mammalian cells. Stains used were laboratory K12 E.coli 
(DH10B), enteropathogenic E.coli (EPEC E2348/69)—wildtype and T3SS-deficient (cfm-14) mutant9, 
Salmonella enterica serovar Typhimurium (S. Typhimurium SL1344)—wildtype and T3SS-deficient 
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(SPI-1) mutant37—[kindly provided by Dr Anjam Khan, Newcastle University, UK]. A plasmid (pJ241) 
expressing a LacZ::RFP fusion protein (pJ241) was generated by cloning into a pUC-derived plasmid the 
synthesized DNA fragments (DNA 2.0) corresponding to the 192 bp region of the E.coli lacZ promoter 
and 726 bp of a codon-optimized derivative which encodes monomeric RFP38. The bacterial EFGP-
expressing plasmid was from (Clontech). HeLa (ATCC, CCL-2), Caco-2 (ATCC, HTB-37), T84 (ATTC, 
CCL-248) and TC-739 cells were cultured as described8,9.
Bacterial Translocation and Invasion assays. Mammalian cells (seeded at ~100% confluence in 
Transwells inserts containing 3 μ m pores; Corning) were routinely differentiated over 15 days, unless 
otherwise indicated, while HeLa cells were used 1 day post-confluence—as detach if left longer—with 
Transepithelial Electrical Resistance (TER) values measured as described7. Bacteria—often carrying an 
ampicillin resistance-encoding plasmid—were grown in Luria broth overnight at 37 °C (no shaking) and 
diluted 1:10 into Dulbecco’s Modified Eagle’s Medium (DMEM) for a hour (37 °C in 5% CO2 atmosphere) 
prior to adjusting the OD600 optical density to 0.1 (~1 × 108 bacteria/ml) with 100 μ l used for apical or 
basolateral infections. For routine 30 min. basolateral inoculations, Transwell inserts were inverted and 
inoculated 5 min. prior to removing the inoculums and re-inverting inserts into fresh DMEM. 20 μ l 
aliquots were taken from basolateral and/or apical compartments (contain ~0.5 and ~1.5 ml DMEM 
respectively) as appropriate, for serial dilution plating onto agar plates with resulting colony forming 
units, CFU, enumerated using a colony counter (Scientific Lab Supplies). For time course experiments, 
the basolateral well was directly inoculated with 100 μ l of bacterial suspension with sampled (for plating) 
apical volume replaced with DMEM. In some experiment EDTA (10 mM final conc.) was added apically 
(30 min.) to disrupt tight junctions between adjacent epithelia, prior to replacing with DMEM and ini-
tiating infection. For invasion assays, the apical and basolateral surfaces were washed (5 times with ice 
cold PBS) and incubated 1 hr with DMEM containing gentamicin (100 μ g/ml final conc.)—to kill extra-
cellular bacteria—washed and intracellular bacterial released (1% Triton-X100/PBS solution) for agar 
plate-mediated CFU enumeration. When appropriate, nocodazole (Sigma-Aldrich; 10 μ M final conc.) or 
cytochalsinD (Sigma-Aldrich; 5 μ M final conc.) were added to apical and basolateral compartments 3 hr 
prior to and during infection.
Confocal and scanning electron microscopy. Transwell porous supports were excised and 
cell monolayers fixed (2.5% paraformaldehyde/PBS solution) prior to permeabilising (1% Triton 
X-100 in PBS) for staining filamentous actin (TRITC-phalloidin; Sigma-Aldrich) and DNA (DAPI; 
4′ ,6-diamidino-2-phenylindole) as described7. In some experiments FITC-conjugated wheat germ agglu-
tinin (Sigma-Aldrich) was used to label the enterocyte surface membranes, following manufacturer’s 
instructions, while 1 μ m latex beads (polystyrene, fluorescent yellow-green; Sigma-Aldrich) were also 
used as uptake substrates. Cells were examined by confocal microscope using a Leica SP-2 confocal 
microscope as described8,9.
Wounding assay. Cells polarised on 13 mm glass coverslips (VWR) were washed twice with DMEM 
and subjected to wounding (pulling a 10 μ l pipette tip across the cell surface) prior to apical infection 
with GFP-expressing DH10B E.coli (MOI 50:1 for 3 h). Washed, paraformaldehyde-fixed cells were incu-
bated with anti-E.coli antibodies (Abcam, AB13626) to label extracellular bacteria and visualised using 
ALEXA-conjugated secondary antibodies (Invitrogen, A21127).
Statistical analyses. In all cases, unless otherwise stated, experiments were independently repeated 
3 times. Data represents the mean ± SD. Significance within data sets were determined at 0.05 using a 
one-way ANOVA with a post-hoc Tukey test indicating significances between individual, or indicated 
data points.
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